Seth Bilazarian MD has been a Clinical and Interventional Cardiologist at Pentucket Medical Associates in Massachusetts since 1993. He is board certified in Internal Medicine, Cardiovascular Medicine, Nuclear Cardiology, Vascular Ultrasound, Interventional Cardiology, and Vascular and Endovascular Medicine.
Dr Bilazarian performs coronary and peripheral interventions at Lahey Clinic and Massachusetts General Hospital. He has been an investigator in the interventional laboratory for new devices including drug-eluting stents, distal protection devices, imaging devices (OCT and InfraRed), and anticoagulant pharmacotherapy.
Dr Bilazarian is an active participant in clinical trials in congestive heart failure, hypertension, coronary disease prevention, prediabetes management, anemia, atrial fibrillation, and anticoagulation/antiplatelet therapies in the outpatient setting. He has authored numerous papers and book chapters in clinical cardiology. He was appointed as a physician advisor to the circulatory device panel of the FDA in 2008.
Private practice with Dr Seth Bilazarian
View all posts »Welcome to Practioner's Corner Video Blog
Feb 2, 2009 18:11 EST-
1Comments
-
Read later
Welcome to the first edition of Practitioners Corner a new video blog on theheart.org. I am Dr. Seth Bilazarian a clinical and interventional cardiologist in suburban Massachusetts and I was asked to host this blog dealing with issues relevant to practicing physicians and private practice.
The concept of this blog is to discuss issues about implementation of new and old therapies and diagnostics. My hope is that this forum will be relevant to practicing cardiologists. Theheart.org has many other blog and Website presentations which provide a wealth of up to the minute news and information for physicians.
The purpose of this blog is to discuss how these new therapies, new diagnostics and new strategies are being implemented and how they fit in with older strategies.
- Are the predictions by academic leaders and pundits and industry really what’s happening in practices?
- Are the new strategies being adopted?
- Are physicians experiencing impediments to adoption such as issues with pharmacy benefits managers’ acceptance of new drug therapies?
- Are there restrictions by hospitals to adoption of new devices?
- Are your patients reticent to proceed with recommended therapy due to information they have obtained from the media or elsewhere?
I hope that his forum will invite a lively discussion about differences in implementation and be a source for potential problem-solving by different physicians serving different communities and geographies both around the U. S. and around the globe. In the best case, this forum will be the internet equivalent of the information exchanged between colleagues on the bus ride from the hotel to the convention center at the heart meetings: Answering the question – How do you handle that problem in your practice?
Your comments
 |
 |
 |
||
 |
|
 |
||
 |
 |
 |
||
 |
|
|
 |
|
 |
 |
 |
||
 |
|
|
 |
|
|
|
|
||
|
||||
You must be a member (with full membership) to post a comment.
Already a member?
Enjoy all the benefits of theheart.org
With full membership, you can check out our educational and editorial content, search the site, receive our newsletters, join discussions, download slides and much more.
Membership is free!
